Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Filings indexed 397 across all filing types
Latest filing 2024-05-15 Regulatory Filings
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Investor Presentation
Regulatory Filings
2024-05-15 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated May 15, 2024, announcing the financial results for the quarter and financial year ended March 31, 2024. It includes detailed financial performance data such as revenue, EBITDA, PAT, EPS, segmental revenue, and operational highlights. The document also mentions an upcoming earnings conference call. The content is typical of an Earnings Release, which provides key financial highlights for a quarter and fiscal year but does not contain the full detailed financial statements or comprehensive analysis found in an Annual Report or Interim Report. The document is over 10,000 characters, indicating it is not a brief announcement or a report publication notice. Therefore, the most appropriate classification is Earnings Release (ER). FY 2024
2024-05-15 English
Amendment to AOA/MOA
Regulatory Filings
2024-05-15 English
Qualified Institutional Placement
Regulatory Filings
2024-05-15 English
Change in Auditors
Regulatory Filings
2024-05-15 English
Outcome of Board Meeting
Regulatory Filings
2024-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.